Flavonoids as dual inhibitors of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX): molecular docking and in vitro studies

Abstract Background Inflammation is known to involve in many pathological processes of different diseases, but the current therapy causes adverse effects. Thus, there is a great interest for the discovery of flavonoids as a valuable alternative to classical analgesic and anti-inflammatory agent with...

Full description

Bibliographic Details
Main Authors: Muhd Hanis Md Idris, Siti Norhidayu Mohd Amin, Siti Norhidayah Mohd Amin, Nyotia Nyokat, Heng Yen Khong, Manikandan Selvaraj, Zainul Amiruddin Zakaria, Zurina Shaameri, Ahmad Sazali Hamzah, Lay Kek Teh, Mohd Zaki Salleh
Format: Article
Language:English
Published: SpringerOpen 2022-09-01
Series:Beni-Suef University Journal of Basic and Applied Sciences
Subjects:
Online Access:https://doi.org/10.1186/s43088-022-00296-y
_version_ 1818016690503417856
author Muhd Hanis Md Idris
Siti Norhidayu Mohd Amin
Siti Norhidayah Mohd Amin
Nyotia Nyokat
Heng Yen Khong
Manikandan Selvaraj
Zainul Amiruddin Zakaria
Zurina Shaameri
Ahmad Sazali Hamzah
Lay Kek Teh
Mohd Zaki Salleh
author_facet Muhd Hanis Md Idris
Siti Norhidayu Mohd Amin
Siti Norhidayah Mohd Amin
Nyotia Nyokat
Heng Yen Khong
Manikandan Selvaraj
Zainul Amiruddin Zakaria
Zurina Shaameri
Ahmad Sazali Hamzah
Lay Kek Teh
Mohd Zaki Salleh
author_sort Muhd Hanis Md Idris
collection DOAJ
description Abstract Background Inflammation is known to involve in many pathological processes of different diseases, but the current therapy causes adverse effects. Thus, there is a great interest for the discovery of flavonoids as a valuable alternative to classical analgesic and anti-inflammatory agent with dual-inhibitory action, especially on both COX-2 and 5-LOX which can minimize or overcome this problem. Results In the present work, drug-likeness properties of the synthesized flavonoids via Lipinski’s Rule of Five were predicted using QikProp prior to evaluation of their COX and LOX inhibitory activities using enzyme assays. Subsequently, molecular docking was performed using GLIDE to analyse their binding behaviour. The results showed that all compounds obeyed the Lipinski’s Rule of Five. NPC6 and NPC7 had displayed better selectivity towards COX-2 as compared to Indomethacin with less than 50% inhibition against COX-1. In addition, these compounds also inhibited activity of 5-LOX. Their selectivity to COX-2 was due to the binding to hydrophobic region and extends to lobby region near the entrance of COX binding site forming hydrogen bond with Ser530. Interestingly, these compounds showed a similar binding mode as Zileuton in the active site of 5-LOX and formed hydrogen bond interaction with Ala424. Conclusion NPC6 and NPC7 had potential as dual inhibitor of COX-2 and 5-LOX. The scaffolds of these chemical entities are useful to be as lead compounds for the dual inhibition of COX-2 and 5-LOX.
first_indexed 2024-04-14T07:16:10Z
format Article
id doaj.art-96264fcf9d9b45e9ac6cfd2399c2cd30
institution Directory Open Access Journal
issn 2314-8543
language English
last_indexed 2024-04-14T07:16:10Z
publishDate 2022-09-01
publisher SpringerOpen
record_format Article
series Beni-Suef University Journal of Basic and Applied Sciences
spelling doaj.art-96264fcf9d9b45e9ac6cfd2399c2cd302022-12-22T02:06:18ZengSpringerOpenBeni-Suef University Journal of Basic and Applied Sciences2314-85432022-09-011111910.1186/s43088-022-00296-yFlavonoids as dual inhibitors of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX): molecular docking and in vitro studiesMuhd Hanis Md Idris0Siti Norhidayu Mohd Amin1Siti Norhidayah Mohd Amin2Nyotia Nyokat3Heng Yen Khong4Manikandan Selvaraj5Zainul Amiruddin Zakaria6Zurina Shaameri7Ahmad Sazali Hamzah8Lay Kek Teh9Mohd Zaki Salleh10Integrative Pharmacogenomics Institute (iPROMISE), Universiti Teknologi MARA (UiTM) SelangorIntegrative Pharmacogenomics Institute (iPROMISE), Universiti Teknologi MARA (UiTM) SelangorIntegrative Pharmacogenomics Institute (iPROMISE), Universiti Teknologi MARA (UiTM) SelangorFaculty of Applied Sciences, Universiti Teknologi MARA (UiTM) SarawakFaculty of Applied Sciences, Universiti Teknologi MARA (UiTM) SarawakSchool of Engineering, Monash University MalaysiaDepartment of Biomedical Sciences, Faculty of Medicine and Health Sciences, Universiti Malaysia Sabah (UMS)Faculty of Applied Sciences, Universiti Teknologi MARA (UiTM)Faculty of Applied Sciences, Universiti Teknologi MARA (UiTM)Integrative Pharmacogenomics Institute (iPROMISE), Universiti Teknologi MARA (UiTM) SelangorIntegrative Pharmacogenomics Institute (iPROMISE), Universiti Teknologi MARA (UiTM) SelangorAbstract Background Inflammation is known to involve in many pathological processes of different diseases, but the current therapy causes adverse effects. Thus, there is a great interest for the discovery of flavonoids as a valuable alternative to classical analgesic and anti-inflammatory agent with dual-inhibitory action, especially on both COX-2 and 5-LOX which can minimize or overcome this problem. Results In the present work, drug-likeness properties of the synthesized flavonoids via Lipinski’s Rule of Five were predicted using QikProp prior to evaluation of their COX and LOX inhibitory activities using enzyme assays. Subsequently, molecular docking was performed using GLIDE to analyse their binding behaviour. The results showed that all compounds obeyed the Lipinski’s Rule of Five. NPC6 and NPC7 had displayed better selectivity towards COX-2 as compared to Indomethacin with less than 50% inhibition against COX-1. In addition, these compounds also inhibited activity of 5-LOX. Their selectivity to COX-2 was due to the binding to hydrophobic region and extends to lobby region near the entrance of COX binding site forming hydrogen bond with Ser530. Interestingly, these compounds showed a similar binding mode as Zileuton in the active site of 5-LOX and formed hydrogen bond interaction with Ala424. Conclusion NPC6 and NPC7 had potential as dual inhibitor of COX-2 and 5-LOX. The scaffolds of these chemical entities are useful to be as lead compounds for the dual inhibition of COX-2 and 5-LOX.https://doi.org/10.1186/s43088-022-00296-yArachidonic acidInflammationChalconeFlavoneFlavanone
spellingShingle Muhd Hanis Md Idris
Siti Norhidayu Mohd Amin
Siti Norhidayah Mohd Amin
Nyotia Nyokat
Heng Yen Khong
Manikandan Selvaraj
Zainul Amiruddin Zakaria
Zurina Shaameri
Ahmad Sazali Hamzah
Lay Kek Teh
Mohd Zaki Salleh
Flavonoids as dual inhibitors of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX): molecular docking and in vitro studies
Beni-Suef University Journal of Basic and Applied Sciences
Arachidonic acid
Inflammation
Chalcone
Flavone
Flavanone
title Flavonoids as dual inhibitors of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX): molecular docking and in vitro studies
title_full Flavonoids as dual inhibitors of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX): molecular docking and in vitro studies
title_fullStr Flavonoids as dual inhibitors of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX): molecular docking and in vitro studies
title_full_unstemmed Flavonoids as dual inhibitors of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX): molecular docking and in vitro studies
title_short Flavonoids as dual inhibitors of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX): molecular docking and in vitro studies
title_sort flavonoids as dual inhibitors of cyclooxygenase 2 cox 2 and 5 lipoxygenase 5 lox molecular docking and in vitro studies
topic Arachidonic acid
Inflammation
Chalcone
Flavone
Flavanone
url https://doi.org/10.1186/s43088-022-00296-y
work_keys_str_mv AT muhdhanismdidris flavonoidsasdualinhibitorsofcyclooxygenase2cox2and5lipoxygenase5loxmoleculardockingandinvitrostudies
AT sitinorhidayumohdamin flavonoidsasdualinhibitorsofcyclooxygenase2cox2and5lipoxygenase5loxmoleculardockingandinvitrostudies
AT sitinorhidayahmohdamin flavonoidsasdualinhibitorsofcyclooxygenase2cox2and5lipoxygenase5loxmoleculardockingandinvitrostudies
AT nyotianyokat flavonoidsasdualinhibitorsofcyclooxygenase2cox2and5lipoxygenase5loxmoleculardockingandinvitrostudies
AT hengyenkhong flavonoidsasdualinhibitorsofcyclooxygenase2cox2and5lipoxygenase5loxmoleculardockingandinvitrostudies
AT manikandanselvaraj flavonoidsasdualinhibitorsofcyclooxygenase2cox2and5lipoxygenase5loxmoleculardockingandinvitrostudies
AT zainulamiruddinzakaria flavonoidsasdualinhibitorsofcyclooxygenase2cox2and5lipoxygenase5loxmoleculardockingandinvitrostudies
AT zurinashaameri flavonoidsasdualinhibitorsofcyclooxygenase2cox2and5lipoxygenase5loxmoleculardockingandinvitrostudies
AT ahmadsazalihamzah flavonoidsasdualinhibitorsofcyclooxygenase2cox2and5lipoxygenase5loxmoleculardockingandinvitrostudies
AT laykekteh flavonoidsasdualinhibitorsofcyclooxygenase2cox2and5lipoxygenase5loxmoleculardockingandinvitrostudies
AT mohdzakisalleh flavonoidsasdualinhibitorsofcyclooxygenase2cox2and5lipoxygenase5loxmoleculardockingandinvitrostudies